Live Stream Preview | Integrated NK Cell Culture Protocol: A Comprehensive Analysis from Process Development to Application
Release Date:
2026-03-04 16:50
Livestream event time
March 10, 2026, 2:00 PM–3:00 PM
Integrated Solution for Immune Cells and Stem Cells
Hycells Biotechnology is a biotechnology innovation company specializing in research on primary immune cells and hepatocytes. We are committed to providing customers with comprehensive, one-stop solutions for immune cells and stem cells, leveraging scientific innovation to drive industry development and delivering expert services to empower clinical research.
Core Services and Products of Hycells Biotechnology
Compliant Cell Collection Services: The company provides immune cell and stem cell collection services that rigorously adhere to ethical standards and regulatory requirements, ensuring standardized procedures and clear sourcing to establish a compliant foundation for research and translational applications.
High-Quality Serum-Free Culture System – HiXpan Registered trademark Series: HiXpan, independently developed by Hycells Registered trademark Our serum-free culture kits are manufactured using a fully localized, end-to-end domestic production process, with all stages—from raw biological materials to finished products—carried out within China’s domestic supply chain. The kits adhere rigorously to ISO standards for raw material selection, manufacturing management, and quality control. This product series supports the cultivation of immune cells and stem cells with high purity and robust expansion efficiency. Its serum-free, animal-component–free formulation effectively eliminates batch-to-batch variability and the risk of microbial contamination, while meeting GMP manufacturing requirements and IND submission criteria, thereby helping customers significantly reduce regulatory and R&D risks.
Hycells, guided by the principles of “compliance as the cornerstone and practical effectiveness as the guiding principle,” has developed a comprehensive, benchmark integrated NK cell culture solution for clients:
Compliance First : Ensure strict compliance with industry regulations and ethical standards throughout the entire process to safeguard the project.
Policy implementation : Conduct in-depth analysis and effective implementation of key industry policies such as “818,” and proactively mitigate compliance risks.
Reduce costs and increase efficiency : By optimizing the manufacturing process, cost control and efficiency improvements can be achieved while ensuring cell quality and functionality.
Data-driven : Validate the effectiveness of the solution with rigorous experimental data, and highlight the value of the service through genuine customer feedback.
Full support : Providing end-to-end, full-process technical support spanning experimental design, process development, and scale-up to commercial production.
Online Special Topic Sharing Announcement
On Tuesday, March 10, 2026, from 2:00 PM to 3:00 PM, Xu Yuandong, Product Technology Manager at Heyou Biotechnology, will host a live webinar on “Integrated NK Cell Culture.” The session will provide an in-depth analysis of culture processes, cutting-edge solutions, and real-world industry applications, helping you unlock new possibilities in cell culture. Please scan the QR code in the image to register for this exclusive online event. We look forward to connecting with you in the digital space!
Lecturer Biography
Speaker: Xu Yuandong
Subject: NK Integrated Training Program
With nearly a decade of deep expertise in immune cell culture, the company is dedicated to the continuous optimization of culture processes for NK cells, γδ T cells, and human mesenchymal stem cells. By precisely understanding customer needs, it designs tailored, high-efficiency, stable, and GMP-compliant culture protocols that help clients overcome critical technical bottlenecks and accelerate the translation of research findings into commercial products. Backed by a strong scientific foundation and extensive industrialization experience, the company provides end-to-end solutions—covering everything from cell isolation and expansion to functional validation—for numerous leading companies in the greater health and biotechnology sectors.
Related News
HiXpan® Cell Culture Additive: Answers to Key Questions (Part 2)
Hycell’s maximum production capacity per batch is 200–400 units of the 500 mL format, ensuring stable supply and meeting customers’ ongoing production needs.
HiXpan® Cell Culture Additive: Key Questions and Answers (Part 1)
The blood‑derived raw materials used in HiXpan® cell culture additives comply with all regulatory requirements throughout collection, ethical review, informed consent, and commercial authorization, and are supported by a fully traceable supply chain.
This paper focuses on how Hycells transforms biological variability into engineering‑level determinism through a scientifically informed blending strategy and stringent control at the collection end.
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how Hycells proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board